Massachusetts Financial Services
ENTA icon

Massachusetts Financial Services’s Enanta Pharmaceuticals ENTA Stock Holding History

Massachusetts Financial Services’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,407
Closed -$705K – 896
2020
Q3 		$705K Sell
15,407
-22,703
-60% -$1.1M ﹤0.01% 803
2020
Q2 		$1.91M Buy
+38,110
New +$1.97M ﹤0.01% 690
2014
Q2 		– Sell
-6,670
Closed -$267K – 895
2014
Q1 		$267K Buy
+6,670
New +$242K ﹤0.01% 851

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services's ENTA Position: Q4 2020 in Review

Massachusetts Financial Services sold out of Enanta Pharmaceuticals (ENTA) in Q4 2020, closing a stake of 15,407 shares — an estimated $705K sold.

Massachusetts Financial Services first reported a position in ENTA in Q1 2014 and held it in 3 quarters. The position peaked at $1.91M in Q2 2020. 151 funds tracked by Wall St. Rank hold ENTA as of Q4 2020.

  • Massachusetts Financial Services reported no remaining Enanta Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Massachusetts Financial Services sold 15,407 Enanta Pharmaceuticals shares in Q4 2020, an estimated $705K.
  • Massachusetts Financial Services first reported a position in Enanta Pharmaceuticals in Q1 2014 and held it in 3 quarters.
  • Massachusetts Financial Services's Enanta Pharmaceuticals position peaked at $1.91M in Q2 2020.
  • 151 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2020.

Based on Massachusetts Financial Services's 13F filing for Q4 2020, filed 12 Feb 2021.